期刊文献+

恩替卡韦对慢性乙型病毒性肝炎蜘蛛痣、性激素及病毒水平的影响——附27例报告 被引量:1

Effect of entecavir on spider nevi,sex hormone and HBV DNA level in patients with chronic hepatitis B
下载PDF
导出
摘要 目的:观察恩替卡韦对慢性乙型病毒性肝炎(CHB)患者蜘蛛痣、性激素及病毒水平的影响。方法:54例HBeAg阳性的CHB患者分为观察组及对照组各27例,分别给予恩替卡韦及拉米夫定治疗6个月,比较两组治疗前后的蜘蛛痣数量及直径、性激素水平、病毒学及肝功能的变化。结果:治疗前两组患者的蜘蛛痣数量、直径、性激素水平、病毒学及肝功能指标比较差异均无统计学意义(P均>0.05),蜘蛛痣部位以胸前为主。与对照组比较,观察组治疗后的蜘蛛痣数量更少、直径更短,血浆睾酮水平更高、雌二醇水平更低,HBV DNA及HBsAg水平更低,肝功能好转更为明显(P<0.05或0.01)。Pearson参数法分析表明,HBV DNA水平与蜘蛛痣的数量、直径均呈正相关(r分别为0.952、0.945,P均<0.01);蜘蛛痣的数量与直径呈正相关(r=0.951,P<0.01)。结论:蜘蛛痣与HBV DNA水平密切相关;恩替卡韦干预对CHB患者蜘蛛痣、性激素、病毒学及肝功能的疗效优于拉米夫定。 Objective: To explore the effect of entecavir(ETV) on spider nevi(SN),sex hormone and HBV-DNA level in patients with chronic hepatitis B(CHB).Methods: Fifty-four HBeAg-positive CHB patients were divided into the observation and control group(both n=27),the former of which were given ETV while the latter were given lamivudine(LAM).All patients were treated for six-months.The amount and diameter of SN,level of sex hormone,quantities of HBV-DNA and HBsAg together with liver function were compared before and after treatment.Results: There was no significant difference of amount and diameter of SN between the two groups before treatment,and the SN were mainly found in bosom.Compared with the control group,less and smaller SN were found in the observation group(P0.05 and P0.01,respectively).Furthermore,higher level of plasma testosterone as well as lower level of estradiol,HBV DNA,HBsAg and better liver function were all found in the observation group when compared to the control group(all P0.05).Pearson correlation analysis showed that the log of HBV-DNA correlated positively with both the amount and diameter of SN(all r0.09 and P0.01).Conclusion: The amount and diameter of SN were significantly related to HBV-DNA.Compared with LAM,ETV was more effective on regulating the development of spider nevi,level of sex hormone and HBV-DNA level in patients with CHB.
出处 《新医学》 2011年第6期359-362,F0003,共5页 Journal of New Medicine
关键词 蜘蛛痣 性激素 乙型肝炎病毒脱氧核糖核酸 恩替卡韦 拉米夫定 Spider nevi Sex hormone HBV DNA Entecavir Lamivudine
  • 相关文献

参考文献11

  • 1SHARMA V, AGGARWAL S. Spider nevi and chronic liver disease [ J ]. Indian J Dermatol Venereol Leprol, 2009, 75 (4): 403.
  • 2VEDAMURTHY M, VEDAMURTHY A. Spider nevi: a presenting feature of chronic liver disease [ J ]. Indian J Dermatol Venereol Leprol, 2008, 74 (4): 397-398.
  • 3ROMAGNUOLO J, ANDREWS C N, BAIN V G, et al. Simple clinical variables predict liver histology in hepatitis C- prospective validation of a clinical prediction model [J]. Scand J Gastroenterol, 2005, 40 (11) : 1365- 1371.
  • 4NUR F A, CLEMENTE C, SERINO G, et al. Atypical esophageal vascular lesions observed in liver cirrhosis [J]. Dis Esophagus, 2010, 23 (1): E9-E11.
  • 5NIEDERAU C, LANGE S, FRUHAUF M, et al. Cutaneous signs of liver disease : value for prognosis of severe fibrosis and cirrhosis[J]. Liver Int, 2008, 28 (5) : 659- 666.
  • 6KATZ L H, TUR-KASPA R, GUY D G, et al. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation [ J/CD ]. Cochrane Database Syst Rev, 2010, (7) : CD006005.
  • 7姚光弼,陈成伟,陆纬伦,任红,谭德明,王宇明,徐道振.恩替卡韦和拉米夫定治疗慢性乙型肝炎二年病毒学、血清学和生化结果的随机对比研究[J].肝脏,2008,13(1):2-6. 被引量:48
  • 8李红,王志毅,张大志,石小枫,周智,任红.恩替卡韦治疗拉米夫定失效的慢性乙型肝炎患者5年的临床疗效[J].中华肝脏病杂志,2009,17(5):338-341. 被引量:10
  • 9贾杰,吴彪.慢性乙型病毒性肝炎抗病毒治疗机制的研究现状[J].新医学,2008,39(2):118-120. 被引量:14
  • 10IDE T, SATA M, CHAYAMA K, et al. Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from Lamivudine therapy[ J]. Hepatol Int, 2010, 4 (3): 594-600.

二级参考文献26

共引文献69

同被引文献4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部